Adaptive Biotechnologies Corp (NASDAQ: ADPT) on Tuesday, plunged -4.29% from the previous trading day, before settling in for the closing price of $7.70. Within the past 52 weeks, ADPT’s price has moved between $2.28 and $8.33.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 21.12%. The company achieved an average annual earnings per share of 28.53%. With a float of $142.73 million, this company’s outstanding shares have now reached $147.56 million.
Let’s determine the extent of company efficiency that accounts for 709 employees. In terms of profitability, gross margin is 53.84%, operating margin of -93.9%, and the pretax margin is -110.17%.
Adaptive Biotechnologies Corp (ADPT) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Adaptive Biotechnologies Corp is 3.28%, while institutional ownership is 94.31%. The most recent insider transaction that took place on Nov 18 ’24, was worth 1,235. In this transaction Chief Financial Officer of this company sold 248 shares at a rate of $4.98, taking the stock ownership to the 154,330 shares. Before that another transaction happened on Aug 22 ’24, when Company’s SVP and General Counsel sold 26,922 for $4.50, making the entire transaction worth $121,079. This insider now owns 139,365 shares in total.
Adaptive Biotechnologies Corp (ADPT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.68% during the next five years compared to -32.91% drop over the previous five years of trading.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Adaptive Biotechnologies Corp (ADPT) is currently performing well based on its current performance indicators. A quick ratio of 3.38 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.94 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
Looking closely at Adaptive Biotechnologies Corp (NASDAQ: ADPT), its last 5-days average volume was 0.91 million, which is a drop from its year-to-date volume of 1.48 million. As of the previous 9 days, the stock’s Stochastic %D was 35.44%. Additionally, its Average True Range was 0.57.
During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 77.93%, which indicates a significant increase from 51.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.01% in the past 14 days, which was higher than the 86.52% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.57, while its 200-day Moving Average is $4.78. However, in the short run, Adaptive Biotechnologies Corp’s stock first resistance to watch stands at $7.73. Second resistance stands at $8.09. The third major resistance level sits at $8.32. If the price goes on to break the first support level at $7.14, it is likely to go to the next support level at $6.91. Should the price break the second support level, the third support level stands at $6.55.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats
Market capitalization of the company is 1.09 billion based on 147,579K outstanding shares. Right now, sales total 170,280 K and income totals -225,250 K. The company made 46,440 K in profit during its latest quarter, and -32,070 K in sales during its previous quarter.
